Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Vasculitis
•
General Rheumatology
•
Pharmacology
How do you use mesna in your patients who are being started on cyclophosphamide?
Related Questions
How would you approach management of a patient with mixed cryoglobulinemic vasculitis with predominant skin involvement and no major organ involvement?
What options are available for patients who require high dose steroids while taking strong CYP4A4 inducers?
How would you approach management of nodular scleritis in the setting of suspected GCA?
What biologic or conventional/synthetic DMARD would you use as a steroid sparing agent in a patient with GCA and a history of diverticulitis?
Would you start anticoagulation in a previously heathy patient with a new diagnosis of ANCA vasculitis (+PR3, RPGN, crescents on kidney biopsy) who presented with pancreatitis, splenic and renal infarcts and was also found to have CMV viremia?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
How do you approach the management of digital ischemia in a critically ill patient with infection, but no evidence of active rheumatologic disease?
How do you approach cardiovascular risk management in patients with rheumatic disease?
In a patient with SJIA who has been stable on Anakinra however is now planning to conceive or becomes pregnant, would you consider switching to Cimzia?
Does the pattern on chest CT help determine which patients with RA-ILD will respond to immunosuppression?